Cargando…
Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men
According to the Nutritional Prevention of Cancer (NPC) trial, a selenized yeast supplement containing selenium, 200 mcg/day, decreased the incidence of total cancer, cancers of the prostate, colon and lung, and cancer mortality. The active agent in the selenized yeast supplement was assumed to be s...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432259/ https://www.ncbi.nlm.nih.gov/pubmed/28412747 http://dx.doi.org/10.18632/oncotarget.15460 |